Molecular mechanism of norcantharidin inducing apoptosis in liver cancer cells

National Medical Journal of China

Volumn 90, Issue 30, 2010, Pages 2145-2148

  Li, Gong Quan ^a   Zhang, Shui Jun ^a   Lü, Jian Feng ^a,b   Wu, Yang ^a   Li, Jie ^a   Zhang, Gong ^a   Yu, Jiang Tao ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Apoptosis; Bcl 2 gene; Carcinoma, hepatocellular; Norcantharidin

Indexed keywords

CASPASE 3; CASPASE 9; NORCANTHARIDIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; FUSED HETEROCYCLIC RINGS;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CONCENTRATION RESPONSE; DOWN REGULATION; DRUG MECHANISM; FLOW CYTOMETRY; LIVER CANCER; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; WESTERN BLOTTING; CELL PROLIFERATION; DRUG EFFECT; HUMAN; LIVER TUMOR; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BICYCLO COMPOUNDS, HETEROCYCLIC; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LIVER NEOPLASMS;

EID: 84871414832     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.30.015     Document Type: Article

References (13)

1. Chen Y N, Chen J C, Yin S C, et al. Effector mechanisms of norcantharidin - induced mitotic arrest and apoptosis in human hepatoma cells. Int J Cancer, 2002, 100: 158-165.
2. 2007, 87: 2919-2924.
3. 2007, 29:176-180.
4. Ryungsa K, Kazuaki T, Yoko U, et al. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol, 2002, 50:343-352.
5. Rust C, Cores G J. Apoptosis and liver disease. Am J Med, 2000, 108: 567-574.
6. Riedl S, Salvesen G. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol, 2007, 8:405-413.
7. Reed J C. Bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am, 1995, 9:451-473.
8. Dole M G, Jasty R, Cooper M, et al. Bcl-XL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res, 1995, 55:2576-2582.
9. Haldar S, Basu A, Croce C. Bcl2 is the guardian of microtubule integrity. Cancer Res, 1997, 57: 229-233.
10. 1999, 20:350-353.
11. Galluzzi L, Larochette N, Zamzami N, et al. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene, 2006, 25:4812-4830.
12. Vogler M, Dinsdale D, Dyer M J, et al. Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differentiation, 2009, 16:360-367.
13. Akgul C. Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci, 2009, 66:1326-1336.